App-Quantinova.ai

Unique Cause of Renal Infarction: A Case of Pheochromocytoma

SandiyaBindroo - American Society of Nephrology (ASN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Catecholamine

Crystalglobulinemia in Multiple Myeloma: A Rare Case of Survival and Kidney Recovery

AngelaChou - American Society of Nephrology (ASN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Cyclophosphamide

Venous Thromboembolism in Lupus Nephritis by ISN/RPS Biopsy Classification

IanDavidCooley - American Society of Nephrology (ASN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

Hydroxychloroquine

Adeno-Associated Virus-Mediated Factor H Gene Therapy in a Murine Model of Complement-Dependent Thrombotic Microangiopathy and Systemic Thrombophilia

DaisukeIto - American Society of Nephrology (ASN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Venous thrombosis

N/A

Potential Safety Concern of Daprodustat Compared with Injectable Erythropoiesis-Stimulating Agents in Patients with Anemia on Hemodialysis and Not on Dialysis: A Pooled Analysis

TakayukiHamano - American Society of Nephrology (ASN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

The Specificity of Histology in Calciphylaxis

CarlaL.Ellis - American Society of Nephrology (ASN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Nutcracker Syndrome Treatment Complications

RhyanMaditz - American Society of Nephrology (ASN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

ZoMaxx

Factors Determining Timing of Onset of Hypertension in Premature Infants

RandallJenkins - American Society of Nephrology (ASN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Indole-3-Methanol, a Dietary Constituent, Suppresses Uremic Toxicity of Indoxyl Sulfate

SeanRichards - American Society of Nephrology (ASN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

I3C

A Rare Case of Monoclonal Immunoglobulin Deposition Disease (MIDD) in a Transplant Recipient

JosephTasch - American Society of Nephrology (ASN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Everolimus

Allograft Mucormycosis Presenting as AKI

AimenLiaqat - American Society of Nephrology (ASN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

amphotericin

Resolution of High-Output Heart Failure, Recurrent Ascites, and AKI in a Renal Allograft After Ligation of the Arteriovenous Graft

SandeepAPadala - American Society of Nephrology (ASN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Congenital disorder

Venous thrombosis

N/A

A Rare Complication of a Permanent Haemodialysis Line

Asmaa�Y M�Al- Chidadi - American Society of Nephrology (ASN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The Importance of Monitoring Blood Flow in the Maintenance of Vascular Access in Patients Under Hemodialysis

IoannisGriveas - American Society of Nephrology (ASN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

SODIUM POLYSTYRENE SULFONATE, PRACTICE PATTERNS AND ASSOCIATED ADVERSE EVENT RISK; A NATIONWIDE ANALYSIS FROM THE SWEDISH RENAL REGISTER

Paola Laureati - European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

sodium polystyrene sulfonate

THROMBOSIS AND CARDIOVASCULAR EVENTS AMONG PATIENTS WITH ANCA ASSOCIATED VASCULITIS AND ITS IMPLICATION. A- 32 YEAR COHORT STUDY

Teresa Olea - European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

N/A

PRE-EMPTIVE CORRECTION OF PERIPHERAL FISTULA VEIN STENOSIS: AIR REFUELING

Aleksei Zulkarnaev - European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

IN SEARCH OF AN OPTIMAL SCREENING PROGRAM FOR DETECTING STENOSIS AND PREDICTING THROMBOSIS IN ARTERIOVENOUS GRAFT: A DIAGNOSTIC COMPARATIVE ANALYSIS OF THE CURRENTLY AVAILABLE TOOLS

Nicola Tessitore - European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

NO DIFFERENCE OF ARTERIOVENOUS FISTULA SUCCESSFUL CREATION AND MATURATION BETWEEN DIABETIC AND NON-DIABETIC PATIENTS AFTER THREE MONTHS OF SURGERY: THE BENEFICIAL ROLE OF PREOPERATIVE DOPPLER ULTRASOUND

Nikola Gjorgjievski - European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

WOUNDCLOT FOR BLEEDING MANAGEMENT IN ARTERIO-VENOUS FISTULAS FOR HEMODIALYSIS

Orit Kliuk-Ben Bassat - European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Filters

7277 Abstracts